Home › Compare › CEOS vs JEPQ

CEOS vs JEPQ: Dividend Comparison 2026

CEOS yields 76923.08% · JEPQ yields 11.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CEOS wins by $3.5207463509675137e+25M in total portfolio value
10 years
CEOS
CEOS
● Live price
76923.08%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.5207463509675137e+25M
Annual income
$35,117,657,238,443,270,000,000,000,000,000.00
Full CEOS calculator →
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
● Live price
11.10%
Share price
$55.52
Annual div
$6.16
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.8K
Annual income
$2,152.59
Full JEPQ calculator →

Portfolio growth — CEOS vs JEPQ

📍 CEOS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCEOSJEPQ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CEOS + JEPQ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CEOS pays
JEPQ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CEOS
Annual income on $10K today (after 15% tax)
$6,538,461.54/yr
After 10yr DRIP, annual income (after tax)
$29,850,008,652,676,780,000,000,000,000,000.00/yr
JEPQ
Annual income on $10K today (after 15% tax)
$943.83/yr
After 10yr DRIP, annual income (after tax)
$1,829.70/yr
At 15% tax rate, CEOS beats the other by $29,850,008,652,676,780,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CEOS + JEPQ for your $10,000?

CEOS: 50%JEPQ: 50%
100% JEPQ50/50100% CEOS
Portfolio after 10yr
$1.7603731754837569e+25M
Annual income
$17,558,828,619,221,635,000,000,000,000,000.00/yr
Blended yield
99.74%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CEOS buys
0
JEPQ buys
0
No recent congressional trades found for CEOS or JEPQ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCEOSJEPQ
Forward yield76923.08% ✓11.10%
Annual dividend / share$2.00$6.16 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$3.5207463509675137e+25M$44.8K ✓
Annual income after 10y$35,117,657,238,443,270,000,000,000,000,000.00 ✓$2,152.59
Total dividends collected$3.520157521397876e+25M$16.3K ✓
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: CEOS vs JEPQ ($10,000, DRIP)

YearCEOS PortfolioCEOS Income/yrJEPQ PortfolioJEPQ Income/yrGap
1← crossover$7,703,008$7,692,307.69$11,930$1,110.39+$7.69M → CEOS
2$5,545,990,379$5,537,748,161.26$14,133$1,224.34+$5545.98M → CEOS
3$3,732,151,735,917$3,726,217,526,211.36$16,632$1,340.46+$3732151.72M → CEOS
4$2,347,491,508,714,269$2,343,498,106,356,837.00$19,454$1,457.97+$2347491508.69M → CEOS
5$1,380,119,533,083,814,100$1,377,607,717,169,489,700.00$22,626$1,576.08+$1380119533083.79M → CEOS
6$758,404,537,995,947,800,000$756,927,810,095,548,100,000.00$26,175$1,694.09+$758404537995947.75M → CEOS
7$389,547,620,856,236,000,000,000$388,736,128,000,580,400,000,000.00$30,133$1,811.32+$389547620856236032.00M → CEOS
8$187,025,031,600,452,680,000,000,000$186,608,215,646,136,520,000,000,000.00$34,531$1,927.17+$187025031600452665344.00M → CEOS
9$83,931,094,609,218,200,000,000,000,000$83,730,977,825,405,720,000,000,000,000.00$39,403$2,041.08+$8.39310946092182e+22M → CEOS
10$35,207,463,509,675,137,000,000,000,000,000$35,117,657,238,443,270,000,000,000,000,000.00$44,787$2,152.59+$3.5207463509675137e+25M → CEOS

CEOS vs JEPQ: Complete Analysis 2026

CEOS — Stock

Psykey, Inc. engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market. Its retail products include functional mushroom coffees and teas, oral supplements, and single serve drink mixes. The company was formerly known as CeCors, Inc. and changed its name to Psykey, Inc. in August 2021. Psykey, Inc. was founded in 2002 and is based in Toronto, Canada.

Full CEOS Calculator →

JEPQ — ETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →
📬

Get this CEOS vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CEOS vs SCHDCEOS vs JEPICEOS vs OCEOS vs KOCEOS vs MAINCEOS vs XYLDCEOS vs QYLDCEOS vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.